Thrombolysis in Childhood Stroke: Report of 2 Cases and Review of the Literature
Stroke 40:801-807, Arnold,M.,et al, 2009
Can a Subset of Intracerebral Hemorrhage Patients Benefit from Hemostatic Therapy with Recombinant Activated Factor VII?
Stroke 40:833-840, Mayer,S.A.,et al, 2009
Disappearing Hyperdense Middle Cerebral Artery Sign in Ischaemic Stroke Patients Treated with Intravenous Thrombolysis: Clinical Course and Prognostic Significance
JNNP 80:273-278,248, Kharitonova,T.,et al, 2009
The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009
Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis
Stroke 40:1710-1720, Earnshaw,S.R.,et al, 2009
Identifying Patients at High Risk for Poor Outcomes After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke 40:1780-1785, Hallevi,H.,et al, 2009
Telemedicine Versus Telephone for Remote Emergency Stroke Consultations: A Critically Appraised Topic
The Neurologist 15:163-166, Capampngan,D.J.,et al, 2009
Thrombolysis in Young Adults with Ischemic Stroke
Stroke 40:2085-2091, Putaala,J.,et al, 2009
4.5 Hours: The New Time Window for Tissue Plasminogen Activator in Stroke
Stroke 40:2266-2267, Davis,S.M. &Donnan,G.A., 2009
Expansion of the Time Window for Treatment of Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator: A Science Advisory from the American Heart Association/American Stroke Association
Stroke 40:2945-2948, del Zoppo,G.J.,et al, 2009
MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009
Review of Tissue Plasminogen Activator, Ischemic Stroke, and Potential Legal Issues
Arch Neurol 65:1429-1433, Liang,B.A.,et al, 2008
A Case of Cocaine-Induced Basilar Artery Thrombosis
Nat Clin Pract Neurol 4:622-626, MacEwen,C., et al, 2008
Rapid Assessment of Perfusion-Diffusion Mismatch
Stroke 39:75-81, Butcher,K.,et al, 2008
Influence of the Stroke Code Activation Source on the Outcome of Acute Ischemic Stroke Patients
Neurol 70:1238-1243,1232, P�rez de la Ossa,N.,et al, 2008
Is it Time for Neurohospitalists?
Neurol 70:1282-1288, Freeman,W.D.,et al, 2008
Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
Stroke 39:850-856, Diringer,M.N.,et al, 2008
Endovascular Thrombectomy and Thrombolysis for Severe Cerebral Sinus Thrombosis: A Prospective Study
Stroke 39:1487-1490, Stam,J.,et al, 2008
Sonothrombolysis With Transcranial Color-Coded Sonography and Recombinant Tissue-Type Plasminogen Activator in Acute Middle Cerebral Artery Main Stem Occlusion: Results From a Randomized Study
Stroke 39:1470-1475,1404, Eggers,J.,et al, 2008
Intra-Arterial Thrombolysis of Acute Iatrogenic Intracranial Arterial Occlusion Attributable to Neuroendovascular Procedures or Coronary Angiography
Stroke 39:1491-1495, Arnold,M.,et al, 2008
Local Intraarterial Fibrinolysis Administered in Aliquots for the Treatment of Central Retinal Artery Occlusion: The Johns Hopkins Hospital Experience
Stroke 39:1746-1750, Aldrich,E.M.,et al, 2008
Neuroimaging in Acute Posterior Cerebral Artery Infarction
The Neurologist 14:170-180, Finelli,P.F., 2008
Stroke
Lancet 371:1612-1623, Donnan,G.A.,et al, 2008
Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke
Arch Neurol 65:607-611,575, Uyttenboogaart,M.,et al, 2008
Treatment of Childhood Arterial Ischemic Stroke
Ann Neurol 63:679-696, Bernard,T.J.,et al, 2008
Iatrogenic Arterial Perforation During Acute Stroke Interventions
AJNR 29:974-975, Nguyen,T.N.,et al, 2008
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 358:2127-2137,2174, Mayer,S.A.,et al, 2008
Thrombolysis in Patients With Marked Clinical Fluctuations in Neurologic Status Due to Cerebral Ischemia
Arch Neurol 65:1041-1043,1017, Ozdemir,O.,et al., 2008
MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases
AJRN 29:1314-1316, Iosif,C.,et al., 2008
Prognostic Significance of Blood Pressure Variability After Thrombolysis in Acute Stroke
Neurol 71:552-558, Delgado-Mederos,R.,et al., 2008
Treatment of Cervical Artery Dissection: A Systematic Review and Meta-Analysis
JNNP 79:11222-1127, Menon,R.,et al, 2008
Thrombolysis with Alteplase 3-4.5 h After Ischaemic Stroke (SITS-ISTR): An Observational Study
Lancet 372:1303-1309, Wahlgren,N.,et al, 2008
Thrombolysis with Alteplase 3 to 4.5 Hours After Acute Ischemic Stroke
NEJM 359:1317-1329,1393, Hacke,W.,et al, 2008
Symptomatic Intracerebral Hemorrhage and Recanalization After IV rt-PA: A Multicenter Study
Neurol 71:1304-1312, Saqqur,M.,et al, 2008
Ischemic Stroke and ICU Care
Semin Neurol 28:645-656, Llinas, R, 2008
Modafinil For Treatment of Fatigue in Post-Polio Syndrome
Neurol 68:1680-1686, Vasconcelos,O.M.,et al, 2007
Artery of Percheron Thrombolysis
AJNR 28:870-871, Kostanian,V. &Cramer,S.C., 2007
Guidelines for the Early Management of Adults With Ischemic Stroke
Stroke 38:1655-1711, Adams,H.P.,et al, 2007
Usefulness of Checking Platelet Count Before Thrombolysis in Acute Ischemic Stroke
Stroke 38:1639-1640, Cucchiara,B.L.,et al, 2007
Magnetic Resonance Perfusion Diffusion Mismatch and Thrombolysis in Acute Ischaemic Stroke: A Systematic Review of the Evidence to Date
JNNP 78:485-491,443, Kane,I.,et al, 2007
Thrombolysis for Ischemic Stroke in Children. Data From the Natioinwide Inpatient Sample
Stroke 38:1850-1854,1722, Janjua,N.,et al, 2007
Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007
Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Storke 38:1952-1955,1732, Yip,T.R. &Demaerschalk,B.M., 2007
Intra-arterial Therapies for Acute Ischemic Stroke
Neurol 68:2132-2139, Mandava,P. &Kent,T.A., 2007
Consent for Intravenous Thrombolysis in Acute Stroke
Arch Neurol 64:785-792, White-Bateman,S.R.,et al, 2007
Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
Arch Neurol 64:879-881, Libman,R.B.,et al, 2007
Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm
Stroke 38:2279-2283, Saver,J.L., 2007
Acute Ischemic Stroke
NEJM 357:572-529, Bart van der Worp,H. &van Gijn,J., 2007
Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
Stroke 38:2633-2639,2627, Ogawa,A.,et al, 2007
Prediction of Hemorrhagic Transformation After Recanalization Therapy Using T2*-Permeability Magnetic Resonance Imaging
Ann Neurol 62:170-176, Bang,O.Y.,et al, 2007